Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The Food and Drug Administration’s greater reliance on digital tools during the pandemic showed the agency how these tools could be used to expand […]
FDA officials see benefits of pandemic-driven digitalization Read More »
The market is volatile, to say the least – but it’s not entirely bad for biotechs, especially those with innovative science, said McKinsey &
VC still interested in biotech, says McKinsey Read More »
The FDA’s Accelerated Approval Pathway must be preserved against current threats as it has been a lifeline for patients with rare diseases, life-threatening conditions,
FDA Accelerated Approval Pathway must be preserved, experts say Read More »
The COVID-19 pandemic brought anxiety and uncertainty worldwide, and also created challenges from social isolation to supply chain issues to economic instability, which worsened
BIO Unbound: ‘Science is limitless when we limit science less’ Read More »
Asked what this pandemic taught us that will help us prepare for the next one, a panel of experts mentioned the need to improve
COVID lessons on manufacturing, distribution, regulation Read More »
The COVID-19 pandemic shook up the global health care system in ways that were more unique and acute than in years past. Yet, the
How do you get an entire population vaccinated and boosted? Read More »
About 50% of the world’s population are women – and women account for around 85% of spending decisions, said Cathy Friedman, Executive Venture Partner
Women’s health ‘woefully underfunded’ – but that’s changing Read More »
On Day 2, the Good Day BIO Live team brings you exclusive interviews with Johnson & Johnson’s Pierre Theodore, Travere Therapeutics’ Eric Dube, Organon’s Kevin Ali,
Good Day BIO LIVE! from San Diego – watch Tuesday’s episode Read More »
Biotechnology as a sector has a massive impact on Environmental, Social, and Governance (ESG) issues, but one area of growing importance to biotech is
Biotech has the power to impact ESG issues Read More »
Global health equity is a complex problem that impacts every country, and the biotech industry can be part of the solution, according to panelists
Biotech can be part of the solution to health inequity – here’s how Read More »
